Share on Facebook
Share on Twitter
Share on LinkedIn
Share by Email
Print
Havrix Generic Name & Formulations
Legal Class
Rx
General Description
Hepatitis A vaccine, inactivated 720 ELISA Units (EL.U.) per 0.5mL (pediatric), or 1440 EL.U. per 1mL (adult); susp for IM inj; aluminum adsorbed; contains neomycin (trace); preservative-free.
How Supplied
Single-dose vials—10; Single-dose prefilled Tip-Lok syringes—5 (without needles)
Manufacturer
Havrix Indications
Indications
Hepatitis A immunization.
Havrix Dosage and Administration
Adult
Inject into deltoid, preferably at least 2 weeks before expected exposure. >18yrs: 1440 EL.U. once IM; give booster dose 6–12 months after initial course.
Children
Inject IM preferably at least 2 weeks before expected exposure. <12months: not recommended. 12months–18yrs: 720 EL.U. once IM; give booster dose 6–12months after initial course.
Havrix Contraindications
Contraindications
Neomycin allergy. Previous hypersensitivity reaction to hepatitis A-containing vaccine.
Havrix Boxed Warnings
Not Applicable
Havrix Warnings/Precautions
Warnings/Precautions
Have epinephrine (1:1000) inj available. Fever. Bleeding disorders. Immunodeficiency (may have suboptimal response). If given with immune globulin, use separate syringe and different site. Latex allergy. Pregnancy (Cat.C). Nursing mothers.
Havrix Pharmacokinetics
See Literature
Havrix Interactions
Interactions
Immunosuppressives may reduce efficacy. Concomitant vaccines: see literature.
Havrix Adverse Reactions
Adverse Reactions
Inj site reactions, headache, fatigue, fever, malaise, anorexia, GI upset.
Havrix Clinical Trials
See Literature
Havrix Note
Not Applicable
Havrix Patient Counseling
See Literature
